Detail akcie Stereotaxis online

Business Summary: Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Stereotaxis Inc revenues increased 9% to $7.5M. Net loss applicable to common stockholders increased 27% to $6.1M. Revenues reflect Disposables, service and accessories increase of 29% to $5.5M. Higher net loss reflects General and administrative increase of 30% to $4.5M (expense), Sales and marketing increase of 5% to $3.1M (expense).